Keyphrases
Parkinson's Disease
100%
Serum Levels
100%
Vascular Risk Factors
100%
Cognitive Dysfunction
100%
Glypican-4
100%
Parkinson Patients
45%
Dementia
18%
Cerebrospinal Fluid
18%
Biofluids
18%
Four-level
18%
Tear Fluid
18%
Glypican
18%
Synapse
9%
Alzheimer's Disease
9%
Neurodegenerative Diseases
9%
Disease-associated
9%
Diabetes
9%
Control Subjects
9%
Age-dependent
9%
Cardiovascular Disease
9%
Regression Analysis
9%
Clinical Evidence
9%
Cognitive Decline
9%
Western Blot
9%
Risk Stratification
9%
Clinical Biomarkers
9%
Glutamate Receptors
9%
Parkinson's Disease Dementia
9%
Vascular Risk
9%
Co-pathology
9%
CNS Development
9%
MoCA Test
9%
Fluids Samples
9%
Tau Hyperphosphorylation
9%
Medicine and Dentistry
Cognitive Defect
100%
Parkinson's Disease
100%
Glypican
100%
Biological Marker
15%
Cerebrospinal Fluid
15%
Enzyme Linked Immunosorbent Assay
7%
Alzheimer's Disease
7%
Diabetes
7%
Malignant Neoplasm
7%
Synapse
7%
Cardiovascular Disease
7%
Western Blot
7%
Risk Stratification
7%
Neurodegenerative Disorder
7%
Tau
7%
Hyperphosphorylation
7%
Glutamate Receptor
7%
Pharmacology, Toxicology and Pharmaceutical Science
Cognitive Defect
100%
Glypican
100%
Parkinson's Disease
100%
Biological Marker
15%
Enzyme-Linked Immunosorbent Assay
7%
Western Blot
7%
Malignant Neoplasm
7%
Alzheimer's Disease
7%
Glutamate Receptor
7%
Cardiovascular Disease
7%
Neuroscience
Parkinson's Disease
100%
Cognitive Disorders
100%
Glypican
100%
Neurodegenerative Disorder
7%
Western Blot
7%
ELISA
7%
Synapse
7%
Glutamate Receptor
7%
Hyperphosphorylation
7%
Alzheimer's Disease
7%
Immunology and Microbiology
Blood Level
100%
Cerebrospinal Fluid
66%
Liquid
66%
Western Blot
33%
Synapse
33%
ELISA
33%
Biochemistry, Genetics and Molecular Biology
Blood Level
100%
Glypican 4
100%
Liquid
36%
Glypican
18%
Tau
9%
Western Blot
9%
Synapse
9%
Hyperphosphorylation
9%
Glutamate Receptor
9%